S100A14 suppresses metastasis of nasopharyngeal carcinoma by inhibition of NF-kB signaling through degradation of IRAK1
Meng Dong-Fang, Sun Rui, Liu Guo-Ying, Peng Li-Xia, Zheng Li-Sheng, Xie Ping, Lin Si-Ting, Mei Yan, Qiang Yuan-Yuan, Li Chang-Zhi, Xu Liang, Peng Xing-Si, Hu Hao, Lang Yan-Hong, Liu Zhi-Jie, Wang Ming-Dian, Guo Ling-Ling, Xie De-Huan, Shu Di-Tian, Li Hai-Feng, Luo Fei-Fei, Niu Xing-Tang, Huang Bi-Jun, Qian Chao-Nan
Journal:ONCOGENE
IF:7.97
DOI:10.1038/s41388-020-1363-8
PMID:32555330
Published:2020-06-17
research field:癌症研究生物医学工程药学纳米技术
Abstract
Nasopharyngeal carcinoma (NPC) is a unique head and neck cancer with highly aggressive and metastatic potential in which distant metastasis is the main reason for treatment failure. Till present, the underlying molecular mechanisms of NPC metastasis remains poorly understood. Here, we identified S100 calcium-binding protein A14 (S100A14) as a functional regulator suppressing NPC metastasis by inhibiting the NF-kB signaling pathway and reversing the epithelial–mesenchymal transition (EMT). S100A14 was found to be downregulated in highly metastatic NPC cells and tissues. Immunohistochemical staining of 202 NPC samples revealed that lower S100A14 expression was significantly correlated with shorter patient overall survival (OS) and distant metastasis-free survival (DMFS). S100A14 was also found as an independent prognostic factor for favorable survival. Gain- and loss-of-function studies confirmed that S100A14 suppressed the in vitro and in vivo motility of NPC cells. Mechanistically, S100A14 promoted the ubiquitin-proteasome-mediated degradation of interleukin-1 receptor-associated kinase 1 (IRAK1) to suppress NPC cellular migration. Moreover, S100A14 and IRAK1 established a feedback loop that could be disrupted by the IRAK1 inhibitor T2457. Overall, our findings showed that the S100A14-IRAK1 feedback loop could be a promising therapeutic target for NPC metastasis.
本文使用的Yeasen产品


